Home » News: Today at Pittcon: Waters Introduces New Technologies for 2011
News: Today at Pittcon: Waters Introduces New Technologies for 2011
By Paul Thomas, Senior Editor
Waters Corp. today used the opportunity of a press conference at Pittcon 2011 in Atlanta to introduce four key new products for drug product analysis, geared towards applications in labs, pilot plants, and commercial plants:
UltraPerformance SCF Chromatography System: For the first time, said Rohit Khanna, VP of worldwide marketing, there is a UPLC solution that takes advantage of the efficiencies provided by the use of supercritical fluids, “fully exploiting SFC for analytical systems . . . This is not a patched-together system . . . but is built from the ground up from the Acquity system.” In improving efficiency for separations, it is clearly a “green” technology, the company noted.
The product has taken longer to develop than anticipated, Khanna acknowledged, as the challenge of adequately cooling (but not freezing) carbon dioxide to facilitate SFC required changes throughout the Acquity system, not just an “add-on” to the original product.
PATROL UPLC Laboratory Analyzer: A few years ago, Waters introduced PATROL for on-line, and then at-line, analysis on the shop floor. “We are now taking aim at the process development laboratory,” says Khanna. For reaction analysis there has always been, he says, “an unbridgeable gulf between the analytical lab and the process development laboratory—until now.”
Acquity with 2D Technology: The new solution gives Acquity UPLC systems increased resolving power, with greater sensitivity, Waters said.
Biopharmaceutical System with UNIFI: The device combines Waters’ analytical technologies for biopharma characterization into one optimized system, Khanna said. It will be a key technology, in particular, for biosimilar developers, in helping to establish bioequivalence.
UNIFI is the company’s next-generation UPLC/MS software—“the birth of a new generation of lab software,” Khanna said. It’s a workflow focused platform” that will eventually be offered as a standalone product for current Waters’ informatics customers.
Merck Stops Development of Parkinsonís DrugFrom Bloomberg
Merck & Co. will end development of preladenant because a preliminary review of late-stage clinical trials suggests it doesnít work
French Drugmaker on Trial for Suspected DeathsFrom Yahoo! News
Servier Laboratories, French drugmaker responsible for producing diabetes and weight loss drug Mediator, faces charges for deception in relation to the suspected deaths of hundreds of people.
Novo Acquires Xellia Pharmaceuticals for $700 MillionFrom PharmaTimes Online
Novo A/S has acquired Xellia Pharmaceuticals of Norway
Royalty Increases Bid as Elan Unveils AcquisitionsFrom PharmaTimes Online
Royalty Pharma has resurfaced to raise its bid to acquire the Irish drugmaker Elan
New Asthma Drug Offers Hope for PatientsFrom Forbes
An experimental asthma drug could give new hope to patients for whom existing medicines are not enough
Syrian Pharma Production Nearly Halted by WarFrom AFP
A shortage of foreign currency has brought production to a near halt in Syria
Camfil APC Opens Manufacturing Plant in the UKFrom Camfil
Camfil announced the grand opening of its new 40,000-sq.-ft. facility
Actavis Acquiring Warner Chilcott for $8.5BFrom AP
Actavis to buy Warner Chilcott in an all-stock transaction
Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics
NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration
Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com
Agreement creates unique strategic collaboration for development and clinical trial execution
- All news »